Industry / innovation partners

ENDO 2026 reveals the GLP-1 revolution’s real challenge: delivery

Gastric Cancer Gets a New Biomarker Access Signal

Cholesterol prevention is moving earlier. Is Europe ready to treat inherited risk before adulthood?

Gastric Cancer Gets a New Biomarker Access Signal

mRNA Flu Shots Are No Longer a Pandemic Experiment

MRD Testing Moves From Prognosis Toward Treatment Action

AstraZeneca’s Baxfendy opens a new front in uncontrolled hypertension, but monitoring will decide who benefits

India’s emergency price-cap rise for cisplatin and carboplatin exposes a blunt oncology truth

Precision cardiology is becoming the new oncology. Policy and reimbursement must catch up
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
